BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.15% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.66% |
| 4 | Healthcare | 5.15% |
| 5 | Industrials | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XXII
3451
22nd Century Group
XXII
$1.42M
| – | – |
0
| – | – |
|
|
CMRX
3452
DELISTED
Chimerix, Inc.
CMRX
| $33.3K | ﹤0.01% |
7,273
-9,995
| -58% | -$55.7K |
|
3453
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $33.3K | ﹤0.01% |
620
-8,205
| -93% | -$437K |
|
3454
Aldeyra Therapeutics
ALDX
$86.9M
| $33.2K | ﹤0.01% |
7,468
-2,468
| -25% | -$9.83K |
|
3455
Superior Group of Companies
SGC
$210M
| $33.2K | ﹤0.01% |
1,858
-2,778
| -60% | -$55.2K |
|
|
AC
3456
DELISTED
Associated Capital Group
AC
| $33.1K | ﹤0.01% |
790
-960
| -55% | -$39.8K |
|
|
LUNA
3457
DELISTED
Luna Innovations Incorporated
LUNA
| $33.1K | ﹤0.01% |
4,287
-8,145
| -66% | -$58.6K |
|
3458
Atlanticus Holdings
ATLC
$1.47B
| $33K | ﹤0.01% |
638
-1,485
| -70% | -$89.3K |
|
3459
Evolus
EOLS
$530M
| $32.9K | ﹤0.01% |
2,932
-3,900
| -57% | -$33.2K |
|
3460
Perion Network
PERI
$384M
| $32.7K | ﹤0.01% |
1,455
-3,008
| -67% | -$64.1K |
|
3461
Puma Biotechnology
PBYI
$450M
| $32.7K | ﹤0.01% |
11,337
-17
| -0.1% | -$44 |
|
3462
Precision BioSciences
DTIL
$201M
| $32.6K | ﹤0.01% |
353
-157
| -31% | -$21.3K |
|
3463
Fomento Económico Mexicano
FMX
$39.7B
| $32.6K | ﹤0.01% |
393
+63
| +19% | +$4.96K |
|
3464
Honda
HMC
$40.5B
| $32.5K | ﹤0.01% |
1,150
-15,596
| -93% | -$458K |
|
3465
Global X Cloud Computing ETF
CLOU
$281M
| $32.3K | ﹤0.01% |
+1,471
| New | +$32.4K |
|
3466
Consumer Portfolio Services
CPSS
$208M
| $32.3K | ﹤0.01% |
3,181
+629
| +25% | +$7.06K |
|
|
ONCT
3467
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $31.4K | ﹤0.01% |
1,128
-591
| -34% | -$21.5K |
|
|
SLNO
3468
DELISTED
Soleno Therapeutics
SLNO
| $31.2K | ﹤0.01% |
9,335
-11
| -0.1% | -$57 |
|
3469
Fidelity D&D Bancorp
FDBC
$321M
| $31.2K | ﹤0.01% |
672
-800
| -54% | -$39.9K |
|
3470
Allient
ALNT
$1.86B
| $31.2K | ﹤0.01% |
1,044
-2,524
| -71% | -$88.3K |
|
|
CBAY
3471
DELISTED
Cymabay Therapeutics
CBAY
| $31.1K | ﹤0.01% |
9,996
-114,803
| -92% | -$361K |
|
3472
Scholar Rock
SRRK
$6.46B
| $31K | ﹤0.01% |
2,405
-3,475
| -59% | -$59.4K |
|
3473
eGain
EGAN
$206M
| $30.8K | ﹤0.01% |
2,659
-4,288
| -62% | -$48.3K |
|
3474
Viking Therapeutics
VKTX
$3.84B
| $30.6K | ﹤0.01% |
10,206
-15,693
| -61% | -$56.3K |
|
3475
Identive
INVE
$64.1M
| $30.6K | ﹤0.01% |
1,891
-2,666
| -59% | -$51.2K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.